Identification of chromosomal loci associated with non-P-glycoprotein-mediated multidrug resistance to topoisomerase II inhibitor in lung adenocarcinoma cell line by comparative genomic hybridization

Genes Chromosomes and Cancer

Volumn 30, Issue 2, 2001, Pages 136-142

  Struski, Stéphanie ^a   Doco Fenzy, Martine ^b   Trussardi, Aurélie ^c   Masson, Linda ^b   Gruson, Nadine ^b   Ulrich, Evelyne ^b   Proult, Marylène ^a   Jardillier, Jean Claude ^c   Potron, Gérard ^a   Cornillet Lefebvre, Pascale ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b HÔPITAL MAISON BLANCHE   (France)

^c Pharmacy Faculty   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; GLYCOPROTEIN P; GYRASE INHIBITOR;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 17; CHROMOSOME 2P; CHROMOSOME 2Q; CHROMOSOME DELETION; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONCENTRATION RESPONSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE LOCUS; GENE PROBE; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SOUTHERN BLOTTING;

EID: 0035159034     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1071>3.0.CO;2-T     Document Type: Article

References (31)

1. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors
2. Involvement of the ALL-1 gene in a solid tumor
3. Non P-glycoprotein novel protein involved in human cancer multidrug resistance
4. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age
5. A new technic of analysis of the human karyotype
6. Secondary leukemias induced by topoisomerasetargeted drugs
7. Association of germline p53 mutation with JILL segmental jumping translocation in treatment-related leukemia
8. Cytogenetic and molecular characterization of tumors in nude mice derived from multidrugresistant human leukemia cell line
9. 1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment
10. An international system for human cytogenetic nomenclature
11. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors
12. Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals
13. Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervals
14. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-Glycoprotein, in drug-selected cell lines and patients with drug refractory ALL
15. Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines
16. Gains of 1 q21-q22 and 13q12-q14 are potential indicators for resistance to cisplatin-based chemotherapy in ovarian cancer patients
17. Genomic imbalances associated with acquired resistance to platinum analogues
18. Comparative genomic hybridization
19. P-glycoprotein as multidrug transporter: A critical review of current multidrug resistant cell lines
20. Cytogenetic alterations associated with P-glycoprotein- and non-P-glycoprotein-mediated multidrug resistance in SW-1573 human lung tumor cell lines
21. Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors
22. Comparative genomic hybridization analysis of chromosomal alterations induced by the development of resistance to thymidylate synthase inhibitors
23. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: Correlation between chromosomal abnormalities and prior therapy
24. Molecular cytogenetics of multiple drug resistance
25. Cytogenetic alterations associated with the acquisition of doxorubicin resistance: Possible significance of chromosome 7 alterations
26. DNA cleavage within the JILL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis
27. Sequential overexpression of LRP and MRP but not P-gp 170 in VP16 selected A549 adenocarcinoma cells
28. Drug resistance to DNA topoisomerase I and II inhibitors in human leukemia, lymphoma, and multiple myetoma
29. Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells
30. Epipodophyllotoxin-related leukemia: Identification of a new subset of secondary leukemia
31. Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line